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Editor’s key points
† A fibreoptic sensor was
developed which can
measure PO2 continuously
in blood.
† The sensor was tested in
animal models over a
range of PaO2 values.
† The sensor agreed with
conventional blood gas
analysis.
† In a model of cyclical
atelectasis, the sensor
detected arterial PO2
oscillations.
† The sensor has clinical
potential.
Background. There is considerable interest in oxygen partial pressure (PO2) monitoring in
physiology, and in tracking PO2 changes dynamically when it varies rapidly. For example,
arterial PO2 (PaO2 ) can vary within the respiratory cycle in cyclical atelectasis (CA), where
PaO2 is thought to increase and decrease during inspiration and expiration, respectively.
A sensor that detects these PaO2 oscillations could become a useful diagnostic tool of CA
during acute respiratory distress syndrome (ARDS).
Methods.Wedeveloped a fibreoptic PO2 sensor (,200mmdiameter), suitable for human use,
that has a fast response time, and can measure PO2 continuously in blood. By altering
the inspired fraction of oxygen (FIO2 ) from 21 to 100% in four healthy animal models, we
determined the linearity of the sensor’s signal over a wide range of PaO2 values in vivo. We
also hypothesized that the sensor could measure rapid intra-breath PaO2 oscillations in a
large animal model of ARDS.
Results. In the healthy animal models, PaO2 responses to changes in FIO2 were in agreement
with conventional intermittent blood-gas analysis (n¼39) for a wide range of PaO2 values,
from 10 to 73 kPa. In the animal lavage model of CA, the sensor detected PaO2 oscillations,
also at clinically relevant PaO2 levels close to 9 kPa.
Conclusions.We conclude that these fibreoptic PaO2 sensors have the potential to become a
diagnostic tool for CA in ARDS.
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It is commonly accepted that arterial oxygenation remains
essentially constant during the respiratory cycle in the
healthy lung. Only minimal variations have been observed,
with a period corresponding to the breathing period.1–4 In
contrast, in some conditions of lung injury, the arterial
partial pressure of oxygen (PaO2 ) is known to oscillate to a
great extent.5 –7 It is thought that these PaO2 oscillations are
caused by alveolar opening during inspiration, when PaO2
increases, and by alveolar collapse during expiration, when
PaO2 decreases; this phenomenon is called cyclical atelectasis
(CA). This understanding is supported in part byevidence from
imaging studies using, for example, computed tomography
and positron emission tomography scans (reviewed in8
and9) and in part by studies using optical intravascular
sensors, which showed PaO2 oscillations in animal models of
lung injury.6 7 10–13
These insightful investigations have furthered our under-
standing of the relationship between PaO2 levels and lung
mechanics, and have better informed the management of
mechanical ventilation. However, investigations using fast
PaO2 sensors have not yet been conducted in human patients
because earlyembodiments of these sensors contained ruthe-
nium,a toxicmaterial,14whichneeds tobeexposed inorder for
the sensors to achieve a sufficiently rapid response time.15 The
assessment of individual sensors is a critical step when using
these prototype sensors for physiological or medical re-
search.15–17 Furthermore, the relevance of animal studies
and their translation into medical practice remain unclear,
due, for example, to anatomical andpathophysiological differ-
ences between species.
In order to avoid the requirement for a toxic component in
these sensors, we produced a PaO2 sensor based on a platinum
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complex, immobilized in a polymer matrix,18 19 which has the
potential to be safely used in humans, once its reliability is
established in large animal models. We recently showed that
this sensor can detect up to 60 PO2 oscillations per minute
in vitro, simulating the occurrence of CA at a high respiratory
rate.17Wealsoshowedthat,whenexposedtonon-heparinized
blood, the sensor is resistant to blood clotting at least for a
period of 24 h in vivo.17
This sensor has the potential to become a useful diagnostic
tool for CA in theacute respiratorydistress syndrome (ARDS), or
in other clinical scenarios where PaO2 is thought to change
rapidly. Moreover, the continuous real-time PaO2 signal would
provide immediate feedback on the effect of changes in venti-
latory settings, which could be tailored on an individual basis,
possibly leading towards a more personalized form of ventila-
tion therapy.
This studyaimedatestablishing the sensor’s response time,
exploring the PaO2 range over which the sensor can generate
reliable results, using standard blood gas analysis as a
control measurement, and assessing whether it could detect
PaO2 oscillations in an ovine model of ARDS in vivo.
Methods
The methods for the assessment of sensor’s response time
in vitro are presented elsewhere,18 20 and outlined in the Sup-
plementary material.
All theanimal experiments conformed to theNational Insti-
tutes of Health Guidelines for the Use of Laboratory Animals.
The protocols for the linearity experiments at the Charles Uni-
versity, Czech Republic, were approved by the local University
Animal Care Committee. The protocols for the ovine lavage
model studies were approved by the UK Home Office. At the
end of each study, the animals were killed under anaesthesia
with an overdose of pentobarbital (100 mg kg21). Relevant
sections of the ARRIVE guidelines were adhered to.
Assessment of sensor linearity
The in vivo linearity of the polymethyl methacrylate (PMMA)
sensorwasfirstassessed in experimentsat theFacultyofMedi-
cine, Charles University, Plzen, Czech Republic. One female do-
mesticpig (weight38 kg, age3months)was studiedduring the
8 h recovery and stabilization period from surgery, before the
beginning of a separate experiment on the same animal.
Anaesthesia was induced with i.v. propofol (1–2 mg kg21)
and ketamine (2 mg kg21). The trachea was intubated and
the lungs were mechanically ventilated with tidal volumes of
8ml kg21,withaPEEPof6cmH2O,and FIO2 of 35%. The respira-
tory rate was adjusted tomaintain normocapnia. Anaesthesia
wasmaintainedwith continuous infusionsof propofol (1–4mg
kg21h21)plus fentanyl (10–15mgkg21h21).Afterpreparation,
the infusion of fentanyl was decreased to 5 mg kg21 h21, and
maintained until the end of the experiment. Adequacy of an-
aesthesia was determined by end tidal agent monitoring, the
absence of movement, haemodynamic monitoring (heart
rateandarterial pressure), andabsenceof reflexes.Continuous
infusion of RingerfundinTM solution (Braun Melsungen Ag,
Melsungen, Germany) was used as a fluid replacement in
doses of 10 ml kg21 h21 during the preparation and reduced
to 7 ml kg21 h21 thereafter.
ThePMMAsensorwas connected to thephasemeasurement
system,17 and inserted in the femoral artery througha standard
catheter (length 10 cm, diameter 1.2 mm) to monitor PaO2
responses to changes in FIO2 . This was temporarily decreased
to 21%, and then increased to 60%, 80%, and 100%, inter-
spersedwith recovery periods where FIO2 was returned to base-
line (i.e. 35%); each condition lasted for about 4min. The sensor
was calibrated a posteriori, on the basis of the smallest and
greatest PaO2 values, as recorded with standard analysis of
arterial blood gas (ABG, ABL710, Radiometer, Copenhagen,
Denmark). Arterial blood samples were obtained once FIO2 had
been maintained at 21%, 35%, 60%, 80%, 100%, and 35% for
3 min, just before FIO2 was changed to a different concentra-
tion; ABG results were used as a means of comparison with
data continuously recorded through the sensor. The sampling
rate was set at 10 Hz.
Inasecondsetofexperiments, the linearityof thesensorwas
assessed at the University of Bristol, School of Veterinary
Sciences, where a series of FIO2 changes (similar to those pre-
sented above) were applied before induction of lung injury in
three ovine models. Female sheep [weight 69 (2) kg; age 18
months] were obtained from a local commercial farm source.
For these studies, the sensor was calibrated in vivo, on the
basis of standard ABG analysis at baseline (i.e. FIO2¼21%), and
at FIO2 of 35%; this range of values was chosen because it was
associated with PaO2 values of about 11–20 kPa, where ABG
analysis is frequently used. One PMMA sensor was used in
each in vivo study (i.e. one for the porcine model, and three for
the ovinemodels, such that a total of four sensors was used).
Detection of within-breath oscillations
To determine whether the sensor was capable of detecting
within-breathPaO2 oscillations,onesheepwith lavage-induced
lung injury was studied at the School of Veterinary Sciences,
University of Bristol, UK. An 18 G catheter was placed in the
right cephalic vein and anaesthesia was induced with i.v. mid-
azolam (0.4 mg kg21) and propofol to effect (2 mg kg21).
The trachea was intubated and anaesthesia maintained
with isoflurane (1% end-tidal) with the Anaconda system
(SedanaMedical AB, Stockholm, Sweden). The sheepwas posi-
tioned in sternal recumbency, morphine (0.15 mg kg21 i.v.)
was administered together with remifentanil or alfentanil
infusion. Hartmann’s solution was infused i.v. at 10 ml kg21
h21. Adequacy of anaesthesia was determined by end tidal
agent monitoring, the absence of movement, haemodynamic
monitoring (heart rate and arterial pressure), and absence of
reflexes.Acatheterwasplaced inanauricularartery forarterial
pressure measurement. The ECG, direct arterial pressure, SpO2 ,
and end-tidal carbon dioxide were monitored throughout. The
PMMA sensor was positioned in the carotid artery via a standard
arterial catheter (length 8 cm, diameter 0.9mm), the insertion of
which was guided with ultrasound imaging. Ventilation was
achieved with a Siemens Servo 900C mechanical ventilator in
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thepressure-controlmode, andadjusted tomaintainnormocap-
nia (arterial carbon dioxide tension 4–5 kPa). At this
proof-of-concept stage, the respiratory rate was set between 5
and 6 bpm for the detection of PaO2 oscillations, in agreement
with previous studies.6 11 12 21 Although this respiratory rate is
not clinically relevant, it was chosen in order to provoke the
maximum cyclic recruitment and derecruitment, and hence po-
tentially thegreatestPaO2 oscillations.
1122Physiologicalvariables
were continuously monitored with standard patient monitors
(Datex Ohmeda Capnomac Ultima; multi-parameter patient
monitor: Datex AS3). Following baseline measurements, warm
saline lavages were performed (30 ml kg21 0.9% NaCl at about
388C)untilaPaO2/FIO2 ratioof,13kPa(98mmHg)wasachieved,
as recorded by standard arterial blood gas analysis.
Statistical analysis
For the linearity tests, PaO2 values were averaged over the rele-
vant 2 s periods, and comparedwith the associatedABG results.
Results were assessed statistically using analysis of variance
(IBM SPSS Statistics for Windows, Version 20.0; Armonk, NY,
USA). Comparison between results from standard ABG results
and from our sensor was performed with the Bland–Altman
analysis.23–25
Results
Results from the response time of the sensor in vitro experi-
ments are presented in the Supplementary material.
PaO2 values recorded continuously in response to changes in
FIO2 in one anaesthetized, non-heparinized animal (tempera-
ture 388C) and the contemporaneous standard ABG results are
shown in Figure 1. The sensor-recorded PaO2 values matched
those measured by ABG analysis, in a range between 10 and
73 kPa, over a period of 37 min. The agreement between PaO2
results obtainedwith our sensors and results from the standard
ABG analysis, as observed during FIO2 change experiments, are
given in Figure2. Combiningdata fromovineandporcineexperi-
mentsallowedacollectionof39 samples in total. Thedifference
between recorded sensor values and ABG values marginally
increased at higher values of PaO2 . A Bland–Altman analysis is
shown in Figure 3, which compares results obtained with the
two methods; the bias ratio value appeared small (0.98) with
limits of agreement of 0.73 and 1.24.
Figure 4 shows the results recordedwith the PMMAsensor in
thehealthy lung study [(green lines, inspired fractionof oxygen
(FIO2 ¼ 30%)], where PaO2 remained at about 12 kPa over a
series of five breaths. Figure 4 also shows results following
lung lavage (blue lines, FIO2 ¼ 100%), where PaO2 oscillations
with the same period as respiration were detected in (A) mild,
and (B) severe ARDS.
Discussion
This study presents the first in vivo applications of a novel, fast
intravascular PaO2 sensor, showing its capacity to track PaO2
changes over a wide range, covering physiological and patho-
physiological PaO2 levels, and to detect PaO2 oscillations asso-
ciated with the respiratory period at PaO2 levels close to 9 kPa.
These prototype sensors are not produced in series, hence
differences in performance may vary considerably between
sensors.15 16 In order to avoid uncertainty in the interpretation
of physiological results, it is essential that these sensors
are tested individually, and that their performance is clearly
defined before they are used for physiological studies. This ra-
tionale motivated our in vitro tests, where our sensor’s re-
sponse time was sufficiently fast to track the PaO2 oscillations
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Fig 1 Arterial PO2 responses to FIO2 step changes in one anaesthe-
tized animal (pig) are plotted against time (sampling rate¼10 Hz).
The blue line shows PaO2 recorded by the PMMA sensor, the circles
show results from arterial blood gas sampling at 0, 4, 7, 10, 18, 27,
and 37 minutes; FIO2 at these time points was 21, 35, 60, 80, 100,
and 35% respectively. The dotted horizontal lines highlight the FIO2
values at the time when blood samples were taken.
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Fig 2 PMMA sensor PaO2 results (average value for 2 s) plotted
against standard ABG analysis results (n¼39). Sensors coded
PMMA1, PMMA2, and PMMA3 were used in the ovine models;
sensorPMMA4wasused in theporcinemodel. The identity line illus-
trates the degree of agreement between ABG analysis and the
PMMA sensor.
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that are expected to occur in animalmodels of lung injury. One
limitation of this part of the study was in the testing of the re-
sponse time of the sensor in the gas phase, while the in vivo
measurements were performed in the liquid phase (i.e. in
whole non-heparinized blood). From a technical perspective,
the sensor’s response time is independent of the medium
that it samples, as it is only a function of oxygen diffusion
and solubility within the sensor’s matrix. Moreover, we have
shown in heparinized whole blood that these sensors are
capable of tracking up to 60 PaO2 oscillations per minute;
17
hence, even a relatively slow sensor would be able to follow
the oscillations in our in vivo study (i.e. about 5 min21). The
resultsof these tests ingas (SupplementaryFig.1)arepresented
here for future reference, since it will be easier and cheaper to
test other prototype sensors in gas rather than the liquid phase.
The sensor’s output is temperature-dependent, so calibra-
tion needs to be performed at the temperature at which the
sensor will operate. In this study, our sensors were calibrated
either a posteriori or in vivo, when the temperature was
known and stable. These forms of calibrations are standard
approaches,22 26 27 although we acknowledge that further
work must be done in order to make these sensors more
easily usable for clinical settings, where ‘plug-and-play’
devices are more welcome. In general, a two point calibration
is only practically useful if the sensor’s signal is linear between
these two points. The sensor had avery linear response to PaO2
changes, ranging from clinically relevant, low PaO2 levels, to
rather elevated levels of around 70 kPa; this feature is a
technical improvement over currently used optical sensors,
which are normally designed to monitor either high or low
PO2 levels. In particular, our sensors were in strong agreement
with results from standard blood gas analysis for the lower
part of thePaO2 rangestudied,which is the range that is physio-
logically and clinically most interesting. As oxygen quenches
the fluorescence intensity, the PMMA sensor’s signal is
intrinsically reduced at high PO2 levels, a technical factor that
may have increased the variability of the results and reduced
the degree of agreement with standard ABG for PaO2 values
.40 kPa.
Apart fromtheiraccuracy,oneof thegreatestadvantagesof
these fast sensors is their capacity to record PaO2 continuously,
giving the opportunity to study dynamic PaO2 changes. The
preliminary test of the sensor in vivo in a large animal model
showed that the sensor accurately and rapidly responded to
FIO2 changes, as confirmed by standard ABG analysis. In re-
sponse to a rapid change in FIO2 , the PaO2 response appeared
tobebi-phasic, characterizedbyan initial rapidphase, followed
by a slower one. Although we can only speculate on the im-
plications of this result, it seems possible that ultrafast PaO2
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Fig 4 Continuous recordings of PaO2 for a period of about 1min in a healthyovine lung (green line) and after saline lavages (blue line); the inspired
oxygen fractionwas30%and100%, respectively.PaO2 valuesare shown for (A)mild and (B) severeARDS-like conditions. Respiratory ratewas5bpm
in each experiment. PaO2 oscillations with the same period as breathing were detected in each ARDS model.
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Fig 3 PaO2 values measured using ABG and the PMMA sensor
(n¼39) compared by the Bland–Altman plot; the horizontal axis is
the paired average, and the vertical axis is the paired ratio (ABG/
PMMA). Sensor codes are the same as in given in Figure 2. The
middle solid line represents the bias (0.98), and top and bottom
grey lines represent the 95% limits of agreement [mean ratio (2
SD); SD was 0.13].
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sensors could provide useful information for respiratory physi-
ologyand pathophysiology, in particularwith reference to ven-
tilatory distribution and oxygen uptake efficiency even in the
absence of atelectasis/recruitment.
Fast response time sensors afford the possibility to detect
rapid PaO2 oscillations within breath in real time, like the oscil-
lations that occur in CA.6 7 In this respect, the novelty of our
work does not lay at the proof-of-concept level, but rather in
its potential to confirm this phenomenon in humans. Most im-
portantly, to the best of our knowledge, this study is the first to
show PaO2 oscillations in a clinically relevant range; previous
studies investigated PaO2 levels that are much greater than
those observed in a clinical scenario.6 11 22 26 27 An alternative
approach to assess the degree of variable shunt associated
with CA involves standard ABG analysis, where arterial blood
is sampled close to the end-inspiratory and end-expiratory
stages,13aprocedure that is rathercumbersomeand, inourex-
perience, unreliable.
The within-breath variation in PaO2 levels is thought to be
associated with CA, where gas exchange between alveoli and
pulmonary circulation is impaired during the expiratory phase
of the respiratory cycle, when alveolar collapse occurs.6 7 This
conclusion is also supported by dynamic computed tomog-
raphy, positron emission tomography, and electric impedance
tomography studies, showing less or more dense lung regions,
presumably indicating aerated or collapsed lung.28–31 As in
many previous studies of PaO2 oscillations in models of CA, one
of the limitations of our study was in the lack of direct evidence
of lung collapse, which was assumed on the basis of intermit-
tently low PaO2 values.
The nature of the relationship between the magnitude
of PaO2 oscillations and CA is complex. It is generally
accepted that an increase in the magnitude of PaO2 oscilla-
tions is associated with greater recruitment and derecruit-
ment in CA. However, these phenomena must be looked at
also in consideration of the mean PaO2 ; advanced mathem-
atical modelling characterizing associations and relation-
ships between these variables will contribute to a more
accurate clinical interpretation of the oscillations. Studies
exploring PaO2 oscillations at high mean PaO2 levels have the
advantage of showing very clear oscillations, larger than the
ones shown in this study. This difference in the magnitude of
PaO2 oscillations is observed most likely because at high mean
PaO2 levels, the oxygen–haemoglobin dissociation curve is rela-
tively flat,meaning that small changes in the oxygen content of
arterial blood (aswould result fromalveolar recruitment)would
change the oxygen partial pressure considerably. Our study
shows that these PaO2 oscillations are also detectable at a low
meanPaO2 , affordingapotential usefulnessof the sensor inclin-
ical settings.
In order to test the full potential of these fast sensors in
diagnosing CA and in managing mechanical ventilation,
further research in large animal models of ARDS is required
to facilitate comparison with human adult and paediatric
patients. Moreover, whether anatomical and physiological
differences between species affect PaO2 oscillations in ARDS
is unclear, so it is becoming more and more urgent to
perform such studies in patients with ARDS, and inmechanic-
ally ventilated patients.
Supplementary material
Supplementary material is available at British Journal of
Anaesthesia online.
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